• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pharmacol Rep . Ocular microvascular changes in COVID-19: role of hypoxia, D-dimer, IL-6 and systemic treatment

tetano

Editor, Senior Moderator
Pharmacol Rep


. 2025 May 26.
doi: 10.1007/s43440-025-00738-1. Online ahead of print. Ocular microvascular changes in COVID-19: role of hypoxia, D-dimer, IL-6 and systemic treatment

Magdalena Kal[SUP] 1 2 [/SUP], Michał Brzdęk[SUP] 3 4 [/SUP], Izabella Karska-Basta[SUP] 5 6 [/SUP], Piotr Rzymski[SUP] 7 [/SUP], Antonio Pinna[SUP] 8 [/SUP], Mateusz Winiarczyk[SUP] 9 [/SUP], Jerzy Mackiewicz[SUP] 9 [/SUP], Dominik Odrobina[SUP] 1 [/SUP], Dorota Zarębska-Michaluk[SUP] 1 10 [/SUP]



Affiliations
Abstract

Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been associated with endothelial dysfunction, which may also compromise the microcirculation within ocular tissues. This prospective study evaluated associations between radial peripapillary capillary (RPC) vessel density (VD) and systemic treatment, age, hypoxia, D-dimer, and interleukin-6 (IL-6) levels in patients recovering from coronavirus disease 2019 (COVID-19) related pneumonia.
Methods: Sixty-three individuals who were admitted to the hospital due to COVID-19 bilateral pneumonia underwent ophthalmic examination two months post-discharge. RPC VD was measured using optical coherence tomography angiography. Associations with age, arterial hypertension, and systemic treatment (dexamethasone, remdesivir, and oxygen therapy), oxygen saturation, D-dimer, and IL-6 levels were evaluated. The control group comprised 43 control participants with no history of COVID-19 who attended routine ophthalmic examinations.
Results: No ophthalmic abnormalities were detected. RPC VD did not differ significantly with hypertension or systemic treatment with dexamethasone and remdesivir. However, patients receiving oxygen therapy had higher RPC VD. A borderline inverse correlation was observed between inferior RPC VD and age. There were no correlations between RPC VD and oxygen saturation. Significant inverse correlations were found between nasal RPC and mean RPC with D-dimer levels and between inferior RPC VD and IL-6 levels. No significant differences in RPC parameters were observed when comparing the COVID-19 group with controls.
Conclusions: Hypertension or systemic treatment had no significant effect on RCP VD. However, VD in specific RPC areas correlated inversely with D-dimer and IL-6 levels, highlighting the need for monitoring peripapillary microvasculature for potential long-term ocular effects of COVID-19.

Keywords: Hypoxia; Inflammation; Ophthalmology; Optical coherence tomography angiography; Peripapillary vessel density; SARS-CoV-2.

 
Back
Top Bottom